Development and Testing of Adolescent Twelve-Step Facilitation



Status:Completed
Conditions:Psychiatric
Therapuetic Areas:Psychiatry / Psychology
Healthy:No
Age Range:14 - 21
Updated:3/16/2015
Start Date:October 2011
End Date:May 2015
Contact:Veselina Hristova, B.A.
Email:vhristova@partners.org
Phone:617-643-5927

Use our guide to learn which trials are right for you!

This study is the first to develop and test in a randomized experimental design the efficacy
of an integrated 12-step facilitation intervention tailored for young people. In the first
phase of the study, the investigators are developing and revising a preliminary manual for
the two sessions individually-delivered Motivational Enhancement Therapy (MET) component and
subsequent 8 session group-delivered Cognitive-Behavioral Therapy (CBT) component which will
integrate Twelve-step Facilitation (TSF). Forty adolescents each will complete the
preliminary integrated TSF protocol. In the second phase of the study, the investigators
will compare integrated TSF (iTSF) to standard treatment (MET/CBT) in a randomized
experimental design for adolescent substance use disorder with 60 adolescents. As a result,
the investigators will examine potential mechanisms that may underlie the efficacy of iTSF
in improving alcohol and other drug use outcomes. The investigators will test group
differences on potential mechanisms of change (e.g., Alcoholics Anonymous/Narcotics
Anonymous attendance and involvement) and whether these variables are associated with
substance use outcomes.


Inclusion Criteria:

- Young people between the ages of 14 and 21 that meet criteria for alcohol or other
drug abuse or dependence.

Exclusion Criteria: Youth

- with an active psychotic disorders

- who are in another substance use disorder (SUD) treatment program or receiving SUD
related psychotherapy that could conflict with our treatment

- with a history of severe or complicated withdrawal (e.g., alcohol seizure history)

- who may be using alcohol/drugs prior to study entry at levels likely to result in
severe withdrawal complications, in the absence of any history

- taking addiction treatment medications (e.g., Buprenorphine)

- who cannot speak English because the treatment and assessment instruments will be
conducted in English
We found this trial at
1
site
?
mi
from
Boston, MA
Click here to add this to my saved trials